This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
PSMAddition Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
Uroalerts Men's Health Weekly
June 23, 2026
Videos
Peer-to-Peer Clinical Conversations
Platelet-Rich Therapies for Erectile Dysfunction: A Systematic Review and Meta-Analysis Investigates Efficacy - Helen Bernie
Helen Bernie
Helen Bernie presents a systematic review and meta-analysis of platelet-rich therapies for erectile dysfunction.
View
Practical Approaches to Genetic Testing in Metastatic Hormone-Sensitive Prostate Cancer - Emmanuel Antonarakis
Emmanuel Antonarakis
Emmanuel Antonarakis recommends germline and somatic testing for all metastatic prostate cancer patients.
View
Beyond the Abstracts
Low GATA3 Predicts Worse Survival in Penile Cancer - Beyond the Abstract
Danish National Penile Cancer Database, DaPeCa-Data: Characteristics, Management, and Survival 2000-2025 - Beyond the Abstract
Articles
Editor Selected Abstracts and Commentaries
Male Infertility
Variants in ZZS Complex-Associated Genes TEX11 and M1AP Are Responsible for Male Infertility and Nonobstructive Azoospermia.
Integrating yoga as a holistic intervention in male infertility management: improved sperm parameters and stress reduction: a case report.
Ultrasound localisation microscopy tracks testicular microvascular adaptations to endocrine function in male infertility.
Male Factor Infertility Diagnoses, But Not Male Age, Significantly Affects the Yield of Usable Embryos in Donor Oocyte Cycles.
Peyronie's Disease
Penile curvature surgery in contemporary practice: effectiveness, satisfaction, and complications after corporoplasty in a tertiary referral center.
Erectile Dysfunction
Imaging of the Three-Piece Inflatable Penile Prosthesis.
Phosphodiesterase Type-5 Inhibitors and Glaucoma.
Current Developments and Strategies for Infection Prevention and Management in Penile Implant Surgery.
Grower or Shower: Is It Even a Thing? Penile Growth Patterns and Erectile Dysfunction Aetiology in Growers and Showers.
BPH - Benign Prostatic Enlargement
Anatomy of the Prostatic Urethra and Sphincters: Normal and Pathological Variants.
Pulsed Thulium:YAG laser enucleation versus open simple prostatectomy for large-gland benign prostatic hyperplasia: a retrospective comparative observational study.
An intelligent wearable device based on electrical impedance tomography for dynamic and accurate monitoring of voiding function in patients with benign prostatic hyperplasia: protocol for a single-centre self-controlled diagnostic consistency study.
Impact of High Baseline Post-Void Residual Volume on Outcomes Following Prostatic Artery Embolization.
Redefining clinical success in minimally invasive surgery for BPH: A composite endpoint integrating ejaculatory function, urinary improvement, and safety metrics.
Penile & Urethral Cancers
A focused systematic review and meta-analysis of robot-assisted inguinal lymphadenectomy versus open inguinal lymph node dissection in penile cancer.
Immunohistochemistry for p16 and p53 Provides Substantial Agreement With Molecular Tests in Penile Cancer.
Unveiling the variations in penile cancer care: identifying knowledge gaps and research priorities.
Testicular Cancer
Research trends and collaboration patterns in robotic retroperitoneal lymph node dissection for testicular cancer.
Hyperaccuracy Three-Dimensional Model and Augmented Reality/Mixed Reality for Robot-Assisted Retroperitoneal Lymph Node Dissection in Testicular Cancer.
Prostate Cancer
Current state of the art of new prostate MRI technologies and potential future developments.
Investigation of Potential Splenic Metastasis on Prostate-Specific Membrane Antigen (PSMA) Imaging in High-Risk Prostate Cancer: A Role for MRI?
Surgical Complications in a large series of Retzius-sparing robot-assisted radical prostatectomy: impact of surgical experience and technical modifications (1016 cases).
Direct Androgen Receptor Antagonism Enhances Therapeutic PSMA Radioligand Uptake in Prostate Cancer Models.
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial.
A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound.
Associations of testosterone, sex hormone-binding globulin, and related hormones with risks of cancer death, incident cancer, and incident prostate cancer in men: individual participant data meta-analyses.
Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre-Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors.
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.
Prostate Cancer Working Group 4 Recap.
Association of asymptomatic PSA testing on prostate cancer mortality; a case control study in general practice.
Standardizing PSMA PET/CT reporting in prostate cancer: from structured frameworks to AI-assisted interpretation.
Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparib.
Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study.
Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Nonrandomized Clinical Trial.
Rucaparib - drug evaluation: a PARP inhibitor for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer.
CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancer.
AI-Assisted Prostate Cancer Diagnosis Using Biparametric MRI and PI-RADS v2.1: Performance Comparison Between Novice-Level and Experienced Readers.
Piggybacking Towards Progress for CAR-T Cell Therapy in Prostate Cancer.
The Landscape of Prostate Tumour Methylation.
Prostate Cancer Mortality Among Men with and Without Comorbidity: Long-Term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam - Beyond the Abstract
Single-port robotic radical prostatectomy: early results from a UK centre.
Integrative Oncology for Prostate Cancer: A Narrative Review.
3D Genome Architecture and Epigenetic Regulation of Lineage Identity in Advanced Prostate Cancer.
Targeted Prostate Health Checks for prostate cancer in men at high risk: a feasibility pilot in primary and secondary care in North East London.
Concomitant MRI-detected and MRI-undetected Prostate Cancer with Implications for Biopsy Strategies and Focal Therapy Planning: An Analysis of the PROMIS and PICTURE Trials.
Development and validation of a digital pathology artificial intelligence (DPAI)-derived risk score predicting Gleason grade group reclassification for patients who are candidates for active surveillance.
New Swedish Biopsy Needle Receives FDA Approval – Secures SEK 17 Million in Capital
da Vinci® single-port versus da Vinci® Xi multiport robot-assisted radical prostatectomy for localized prostate cancer: a GRADE-assessed systematic review and meta-analysis.
Intermediate clinical endpoints as surrogates for overall survival after salvage prostatectomy.
Limitations in diagnostics and quantification of small lesions with low uptake in the clinical context of prostate 18F/68Ga-PSMA PET/MRI.
International Delphi consensus on single-port robotic radical prostatectomy: patient selection, surgical technique, and training.
Bayesian re-analysis of ERA223 and PEACE-3 temporal dynamics and bone protection in radium-223-treated metastatic castration-resistant prostate cancer.
CONNECT WITH US
Questions or Comments? Email us at
editors@urotoday.com
Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523
You are receiving this email because you have chosen to receive emails from UroToday.
Add us to your address book
View this email as a web page
Forward to a colleague
Manage your subscriptions
Unsubscribe
Copyright ©2026 Digital Science Press, LLC
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free